Biotech · Private company
Covis Pharma S.à.r.l.
Track this companyFree. Adds Covis Pharma S.à.r.l. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- CiclesonidePhase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- Vascana (0.9% nitroglycerin cream)Phase 2 · Raynaud's Phenomenon Secondary to Connective Tissue DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CiclesonideAllergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 PatientsPHASE3 · COMPLETED · started Jun 8, 2020ClinicalTrials.gov NCT04377711 · fetched Nov 12, 2026
- Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's PhenomenonPHASE2 · COMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT02688270 · fetched Nov 12, 2026
- Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)PHASE4 · COMPLETED · started Apr 1, 2007ClinicalTrials.gov NCT00458835 · fetched Nov 12, 2026